Company ProfilePremium

Cutera

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Cutera - Healthcare showcase

Year Founded & Workforce

1998

540 Employees

Industry

Healthcare

Services

EnlightenExcel HRExcel VExcel V+ LaserJuliet
C

Cutera Employee Contacts

49 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Cutera Overview

Company Headquarters: California, US

Founded: 1998

Workforce: ~540

Company Working: Cutera is a global manufacturer and supplier of laser and energy-based aesthetic systems to practitioners all over the world. The Company creates, develops, manufactures, distributes, and markets light and energy-based product platforms for physicians and other qualified practitioners to employ to provide safe and effective cosmetic treatments to its consumers. Furthermore, the Company sells third party-made skincare items. The Company's continuous research and development activities are primarily focused on the creation of new products as well as the improvement and enhancement of the Company's existing product line.

Strategy

Cutera is dedicated to creating new solutions that employ science and nature to promote health, beauty, and wellness. Furthermore, it seeks to broaden the company's global presence and footprint in both existing and attractive new markets. It intends to investigate possibilities that can supplement and differentiate the company's product portfolio and R&D strategy, expand current leadership, boost competitive positioning, enter new or adjacent markets, and provide long-term financial benefits.

Company Snapshot

$147.7M

Revenue

540

Employees

1998

Founded

California, US

Headquarters

SWOT Analysis

Strengths

  • Strong market presence in established markets
  • Products available globally
  • Diverse portfolio
  • Pioneer in aesthetic medical devices
  • Distribution across 65 countries
  • Leading provider of laser products
  • enLighten product has PICO & Nano technology in the tattoo removal product
  • Worldwide presence in more than 100 countries
  • Strong client base
  • Well established R&D facilities

Weaknesses

  • Company’s manufacturing facilities are limited
  • Inability to develop product in core market of dermatology and plastic surgery.
  • Poor financial performance
  • Reduced patient demand for aesthetic procedure
  • Limited product offerings
  • Highly dependent on the US market for its revenue generation

Opportunities

  • Enhancing the product portfolio by launching products
  • Collaborations to expand geographic reach
  • Opportunities to acquire new ownership stake
  • To increase more product line for the laser removal equipment
  • Expansion the distribution and networking channels overseas
  • Growing demand for microneedling devices
  • Rising awareness about aesthetic products

Threats

  • Stringent government regulations related to import and export
  • Fluctuation in currency
  • Stringent FDA regulations for dermatology and hair laser devices
  • Ensuring the product quality while delivering overseas
  • Ensuring rules and regulations of political and social issues
  • Pricing policies of different countries
  • Increasing competition in the market
  • Changes in government regulations

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
September 2019Product ApprovalCutera received product approval from Health Canada for truSculpt iD Body Sculpting Technology. This will help the company to expand its product portfolio in Canada.
Fiscal year, 2016Product LaunchenLighten III was launched which is used to remove multicolour pigments. The laser was launched with three wavelengths. 1064nm, 532nm and 670nm.
2016FDA ApprovalFDA approved enLighten III laser with wavelength of 670nm. The product include PICO+NANO technology.
December, 2014Product LaunchenLighten laser was launched with the wavelength of 1064nm and 532nm.
July 2022Product LaunchCutera has announced the wider European availability of its award-winning fractional radio frequency (RF) microneedling technology, Secret RF. The skin revitalization platform is available to practitioners throughout most of Europe, including France, Germany, Austria, and Spain.
April 2019Product ApprovalCutera reported that the Secret RF system has been given a Medical Device License by Health Canada, Canada's healthcare regulatory authority.

Product Offering

  • Cutera
    • Enlighten
    • Excel HR
    • Excel V
    • Excel V+ Laser
    • Juliet
    • Secret RF
    • Trusculpt flex
    • TruSculpt iD
    • TruSculpt 3D
    • Xeo
    • Tattoo Removal Laser
    • RF Microneedling Device
    • RF Microneedling Market

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 147.7 Mn in 2020 to USD 252.4 Mn in 2022.
Cutera — By Business Segment
Series (USD Mn)202020212022
Sales147.7231.3252.4
R&D Expenses14.321.625.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.